Table 2 Differential testing of microbial relative abundance.
From: Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies
Filifactor | Parvimonas | Porphyromonas | |
|---|---|---|---|
Median (IQR) | |||
Controls | 0.12 (0.05–0.25) | 0.38 (0.12–1.02) | 3.0 (2.0–5.1) |
EoE baseline | 0 (0–0.13) | 0.11 (0–0.22) | 1.3 (0.6–3.0) |
EoE post-treatment | 0 (0–0.11) | 0.22 (0–0.38) | 0.9 (0.2–2.5) |
Subjects with % > 0 | 31 (47.7%) | 45 (69.2%) | 60 (92.3%) |
BH-adjusted p-values (FDR) | |||
Controls vs. EoE baseline | 0.090 | 0.003 | 0.047 |
Controls vs. post-Tx | 0.025 | 0.042 | 0.006 |